New IRAK4 degrader for the treatment of autoimmune diseases presented
Aug. 31, 2023
Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a critical role in innate immunity by acting both as a scaffolding protein and a protein kinase, and its overactivation correlates with several autoimmune disorders.